Patents by Inventor Priya Vazirani

Priya Vazirani has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS FOR TREATING EPILEPSY
    Publication number: 20200188362
    Abstract: Provided herein are methods of treating, preventing, ameliorating or managing a nonsense mutation mediated epileptic disease, comprising administering a 1,2,4-oxadiazole benzoic acid to a patient having a nonsense mutation mediated epileptic disease. In particular, provided herein are methods of treating, preventing, ameliorating or managing a CDKL5 and/or SCN1A (Dravet syndrome) nonsense mutation mediated epileptic disease.
    Type: Application
    Filed: November 7, 2019
    Publication date: June 18, 2020
    Applicant: PTC Therapeutics, Inc.
    Inventors: Ellen Welch, Yuki Tomizawa, Priya Vazirani
  • Methods for treating epilepsy
    Patent number: 10517853
    Abstract: Provided herein are methods of treating, preventing, ameliorating or managing a nonsense mutation mediated epileptic disease, comprising administering a 1,2,4-oxadiazole benzoic acid to a patient having a nonsense mutation mediated epileptic disease. In particular, provided herein are methods of treating, preventing, ameliorating or managing a CDKL5 and/or SCN1A (Dravet syndrome) nonsense mutation mediated epileptic disease.
    Type: Grant
    Filed: October 28, 2016
    Date of Patent: December 31, 2019
    Assignee: PTC Therapeutics, Inc.
    Inventors: Ellen Welch, Yuki Tomizawa, Priya Vazirani
  • METHODS FOR TREATING EPILEPSY
    Publication number: 20180333397
    Abstract: Provided herein are methods of treating, preventing, ameliorating or managing a nonsense mutation mediated epileptic disease, comprising administering a 1,2,4-oxadiazole benzoic acid to a patient having a nonsense mutation mediated epileptic disease. In particular, provided herein are methods of treating, preventing, ameliorating or managing a CDKL5 and/or SCN1A (Dravet syndrome) nonsense mutation mediated epileptic disease.
    Type: Application
    Filed: October 28, 2016
    Publication date: November 22, 2018
    Applicant: PTC Therapeutics, Inc.
    Inventors: Ellen Welch, Yuki Tomizawa, Priya Vazirani